Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Augmentation regimens for depression.

C B Nemeroff1

  • 1Department of Psychiatry and Pharmacology, Duke University Medical Center, Durham, N.C. 27710.

The Journal of Clinical Psychiatry
|May 1, 1991
PubMed
Summary

When initial antidepressant treatment fails for depression, clinicians can potentiate medication effects with thyroid hormone (T3) or lithium. These augmentation strategies help convert nonresponders into responders, improving treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing in-session rumination and its effects on CBT for depression.

Behaviour research and therapy·2022
Same author

Lifelong outcomes and effects on brain and behavior following childhood maltreatment and early life stress: A primer to inform future research.

Pharmacology, biochemistry, and behavior·2022
Same author

Validity and severity thresholds for the depression subscale of the affective self rating scale: An equipercentile equating study using classical test theory.

Journal of affective disorders·2021
Same author

The revolution of personalized psychiatry: will technology make it happen sooner?

Psychological medicine·2017
Same author

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Translational psychiatry·2016
Same author

Brain activation induced by psychological stress in patients with schizophrenia.

Schizophrenia research·2015

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Major depression treatment often involves antidepressant monotherapy.
  • A significant proportion of patients do not achieve remission with initial antidepressant trials.
  • Treatment nonresponse is typically defined as persistent depressive symptoms after 6 weeks of adequate antidepressant dosage.

Purpose of the Study:

  • To detail the utility of thyroid hormone (T3) and lithium as adjuncts to antidepressant therapy.
  • To describe strategies for converting antidepressant nonresponders into responders.
  • To review other augmentation strategies, including combining different antidepressant classes.

Main Methods:

  • Review of existing literature on antidepressant augmentation strategies.
  • Detailed description of the use of T3 and lithium in potentiating antidepressant effects.
  • Brief overview of concurrent antidepressant use.

Main Results:

  • Thyroid hormone (T3) and lithium are effective adjuncts for potentiating antidepressant effects.
  • These augmentation strategies can convert patients who did not respond to initial antidepressant therapy into responders.
  • Concurrent use of two antidepressants from different classes is another viable augmentation option.

Conclusions:

  • Clinicians should consider T3 or lithium augmentation when initial antidepressant therapy is ineffective.
  • Augmentation strategies offer valuable options for managing treatment-resistant depression.
  • Careful patient reassessment and diagnosis are crucial before initiating alternative treatments.

Related Experiment Videos